Global Period Cramp Pain Killer Market

Period Cramp Pain Killer Comprehensive Study by Type (Ibuprofen, Ketoprofen, Naproxen), Application (Endometriosis, Uterine Fibroids, Adenomyosis, Pelvic Inflammatory Disease, Cervical Stenosis), Mode of Prescription (Over the Counter, Prescription), End Users (Individual Use, Specialty Centers), Route of Administration (Oral, Parenteral, Implants), Distribution Channel (Pharmacies, Retail Sales, Others), Pain Type (Mild, Moderate, Severe) Players and Region - Global Market Outlook to 2026

Period Cramp Pain Killer Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Period Cramp Pain Killer Market Scope?
Menstrual cramps (dysmenorrhea) are throbbing or cramping pain in the lower abdomen. Many women experience menstrual cramps just before and during their menstruation. For some women, the discomfort is just annoying. For others, menstrual cramps can be so severe that they interfere with daily activities for a few days each day. Conditions like endometriosis or uterine fibroids can thereby cause menstrual cramps. Treating the cause is key to pain relief. Menstrual cramps that are not caused by another medical condition decrease with age and often get better after childbirth.

The Period Cramp Pain Killer market study is being classified by Type (Ibuprofen, Ketoprofen and Naproxen), by Application (Endometriosis, Uterine Fibroids, Adenomyosis, Pelvic Inflammatory Disease and Cervical Stenosis) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Period Cramp Pain Killer market throughout the predicted period.

Bayer AG (Germany), GlaxoSmithKline plc (United Kingdom), Pfizer Inc. (United States), Teva Pharmaceuticals USA, Inc. (United States), Color Seven Co., Ltd. (South Korea), Beurer GmbH (Germany), Mylan N. V. (United States), Boehringer Ingelheim International GmbH (Germany), PMS4PMS, LLC (United States), Sanofi (France), Nobelpharma Co., Ltd. (Japan), ObsEva (Switzerland), Myovant Sciences Ltd. (United Kingdom), AbbVie Inc. (United States), LIVIA (United States) and Alvogen (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cumberland Pharmaceuticals Inc. (United States), Lupin Pharmaceuticals, Inc. (India), Janssen Pharmaceuticals, Inc. (United States) and Sun Pharmaceutical Industries Ltd. (India).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Period Cramp Pain Killer market by Type, Application and Region.

On the basis of geography, the market of Period Cramp Pain Killer has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In July 2020, Teva Pharmaceuticals USA, Inc., which Takeda holds as a joint business venture in the Japanese market, announced a new strategy for its local trading activities. This strategy has strengthened the company's presence in the Japanese market and drive sales growth. and In March 2018, GlaxoSmithKline Plc. announced the successful agreement with Novartis to acquire full ownership of the consumer healthcare business. This agreement helped the company grow its product portfolio and the company's revenue growth.



Influencing Market Trend
  • Increasing Prevalence of Dysmenorrhea
  • Rising Level of Awareness and Growing Concern about Dysmenorrhea among Women

Market Drivers
  • Rising Pharmaceutical Industries Interest for the Manufacturing Plant
  • Rising Prevalence of Menstrual Cramps
  • Increasing Usage of Medication

Opportunities
  • Increasing Technological Advancement
  • The Involvement of Companies in Developing Innovative Medicines

Restraints
  • The Side Effects and Complications of Long-Term Care

Challenges
  • Conventional Family Values


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Period Cramp Pain Killer, Suppliers and Distributors of Period Cramp Pain Killer, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Ibuprofen
  • Ketoprofen
  • Naproxen
By Application
  • Endometriosis
  • Uterine Fibroids
  • Adenomyosis
  • Pelvic Inflammatory Disease
  • Cervical Stenosis
By Mode of Prescription
  • Over the Counter
  • Prescription

By End Users
  • Individual Use
  • Specialty Centers

By Route of Administration
  • Oral
  • Parenteral
  • Implants

By Distribution Channel
  • Pharmacies
  • Retail Sales
  • Others

By Pain Type
  • Mild
  • Moderate
  • Severe

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Pharmaceutical Industries Interest for the Manufacturing Plant
      • 3.2.2. Rising Prevalence of Menstrual Cramps
      • 3.2.3. Increasing Usage of Medication
    • 3.3. Market Challenges
      • 3.3.1. Conventional Family Values
    • 3.4. Market Trends
      • 3.4.1. Increasing Prevalence of Dysmenorrhea
      • 3.4.2. Rising Level of Awareness and Growing Concern about Dysmenorrhea among Women
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Period Cramp Pain Killer, by Type, Application, Mode of Prescription, End Users, Route of Administration, Distribution Channel, Pain Type and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Period Cramp Pain Killer (Value)
      • 5.2.1. Global Period Cramp Pain Killer by: Type (Value)
        • 5.2.1.1. Ibuprofen
        • 5.2.1.2. Ketoprofen
        • 5.2.1.3. Naproxen
      • 5.2.2. Global Period Cramp Pain Killer by: Application (Value)
        • 5.2.2.1. Endometriosis
        • 5.2.2.2. Uterine Fibroids
        • 5.2.2.3. Adenomyosis
        • 5.2.2.4. Pelvic Inflammatory Disease
        • 5.2.2.5. Cervical Stenosis
      • 5.2.3. Global Period Cramp Pain Killer by: Mode of Prescription (Value)
        • 5.2.3.1. Over the Counter
        • 5.2.3.2. Prescription
      • 5.2.4. Global Period Cramp Pain Killer by: End Users (Value)
        • 5.2.4.1. Individual Use
        • 5.2.4.2. Specialty Centers
      • 5.2.5. Global Period Cramp Pain Killer by: Route of Administration (Value)
        • 5.2.5.1. Oral
        • 5.2.5.2. Parenteral
        • 5.2.5.3. Implants
      • 5.2.6. Global Period Cramp Pain Killer by: Distribution Channel (Value)
        • 5.2.6.1. Pharmacies
        • 5.2.6.2. Retail Sales
        • 5.2.6.3. Others
      • 5.2.7. Global Period Cramp Pain Killer by: Pain Type (Value)
        • 5.2.7.1. Mild
        • 5.2.7.2. Moderate
        • 5.2.7.3. Severe
      • 5.2.8. Global Period Cramp Pain Killer Region
        • 5.2.8.1. South America
          • 5.2.8.1.1. Brazil
          • 5.2.8.1.2. Argentina
          • 5.2.8.1.3. Rest of South America
        • 5.2.8.2. Asia Pacific
          • 5.2.8.2.1. China
          • 5.2.8.2.2. Japan
          • 5.2.8.2.3. India
          • 5.2.8.2.4. South Korea
          • 5.2.8.2.5. Taiwan
          • 5.2.8.2.6. Australia
          • 5.2.8.2.7. Rest of Asia-Pacific
        • 5.2.8.3. Europe
          • 5.2.8.3.1. Germany
          • 5.2.8.3.2. France
          • 5.2.8.3.3. Italy
          • 5.2.8.3.4. United Kingdom
          • 5.2.8.3.5. Netherlands
          • 5.2.8.3.6. Rest of Europe
        • 5.2.8.4. MEA
          • 5.2.8.4.1. Middle East
          • 5.2.8.4.2. Africa
        • 5.2.8.5. North America
          • 5.2.8.5.1. United States
          • 5.2.8.5.2. Canada
          • 5.2.8.5.3. Mexico
    • 5.3. Global Period Cramp Pain Killer (Volume)
      • 5.3.1. Global Period Cramp Pain Killer by: Type (Volume)
        • 5.3.1.1. Ibuprofen
        • 5.3.1.2. Ketoprofen
        • 5.3.1.3. Naproxen
      • 5.3.2. Global Period Cramp Pain Killer by: Application (Volume)
        • 5.3.2.1. Endometriosis
        • 5.3.2.2. Uterine Fibroids
        • 5.3.2.3. Adenomyosis
        • 5.3.2.4. Pelvic Inflammatory Disease
        • 5.3.2.5. Cervical Stenosis
      • 5.3.3. Global Period Cramp Pain Killer by: Mode of Prescription (Volume)
        • 5.3.3.1. Over the Counter
        • 5.3.3.2. Prescription
      • 5.3.4. Global Period Cramp Pain Killer by: End Users (Volume)
        • 5.3.4.1. Individual Use
        • 5.3.4.2. Specialty Centers
      • 5.3.5. Global Period Cramp Pain Killer by: Route of Administration (Volume)
        • 5.3.5.1. Oral
        • 5.3.5.2. Parenteral
        • 5.3.5.3. Implants
      • 5.3.6. Global Period Cramp Pain Killer by: Distribution Channel (Volume)
        • 5.3.6.1. Pharmacies
        • 5.3.6.2. Retail Sales
        • 5.3.6.3. Others
      • 5.3.7. Global Period Cramp Pain Killer by: Pain Type (Volume)
        • 5.3.7.1. Mild
        • 5.3.7.2. Moderate
        • 5.3.7.3. Severe
      • 5.3.8. Global Period Cramp Pain Killer Region
        • 5.3.8.1. South America
          • 5.3.8.1.1. Brazil
          • 5.3.8.1.2. Argentina
          • 5.3.8.1.3. Rest of South America
        • 5.3.8.2. Asia Pacific
          • 5.3.8.2.1. China
          • 5.3.8.2.2. Japan
          • 5.3.8.2.3. India
          • 5.3.8.2.4. South Korea
          • 5.3.8.2.5. Taiwan
          • 5.3.8.2.6. Australia
          • 5.3.8.2.7. Rest of Asia-Pacific
        • 5.3.8.3. Europe
          • 5.3.8.3.1. Germany
          • 5.3.8.3.2. France
          • 5.3.8.3.3. Italy
          • 5.3.8.3.4. United Kingdom
          • 5.3.8.3.5. Netherlands
          • 5.3.8.3.6. Rest of Europe
        • 5.3.8.4. MEA
          • 5.3.8.4.1. Middle East
          • 5.3.8.4.2. Africa
        • 5.3.8.5. North America
          • 5.3.8.5.1. United States
          • 5.3.8.5.2. Canada
          • 5.3.8.5.3. Mexico
    • 5.4. Global Period Cramp Pain Killer (Price)
      • 5.4.1. Global Period Cramp Pain Killer by: Type (Price)
  • 6. Period Cramp Pain Killer: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teva Pharmaceuticals USA, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Color Seven Co., Ltd. (South Korea)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Beurer GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mylan N. V. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. PMS4PMS, LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sanofi (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Nobelpharma Co., Ltd. (Japan)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. ObsEva (Switzerland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Myovant Sciences Ltd. (United Kingdom)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. AbbVie Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. LIVIA (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Alvogen (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Period Cramp Pain Killer Sale, by Type, Application, Mode of Prescription, End Users, Route of Administration, Distribution Channel, Pain Type and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Period Cramp Pain Killer (Value)
      • 7.2.1. Global Period Cramp Pain Killer by: Type (Value)
        • 7.2.1.1. Ibuprofen
        • 7.2.1.2. Ketoprofen
        • 7.2.1.3. Naproxen
      • 7.2.2. Global Period Cramp Pain Killer by: Application (Value)
        • 7.2.2.1. Endometriosis
        • 7.2.2.2. Uterine Fibroids
        • 7.2.2.3. Adenomyosis
        • 7.2.2.4. Pelvic Inflammatory Disease
        • 7.2.2.5. Cervical Stenosis
      • 7.2.3. Global Period Cramp Pain Killer by: Mode of Prescription (Value)
        • 7.2.3.1. Over the Counter
        • 7.2.3.2. Prescription
      • 7.2.4. Global Period Cramp Pain Killer by: End Users (Value)
        • 7.2.4.1. Individual Use
        • 7.2.4.2. Specialty Centers
      • 7.2.5. Global Period Cramp Pain Killer by: Route of Administration (Value)
        • 7.2.5.1. Oral
        • 7.2.5.2. Parenteral
        • 7.2.5.3. Implants
      • 7.2.6. Global Period Cramp Pain Killer by: Distribution Channel (Value)
        • 7.2.6.1. Pharmacies
        • 7.2.6.2. Retail Sales
        • 7.2.6.3. Others
      • 7.2.7. Global Period Cramp Pain Killer by: Pain Type (Value)
        • 7.2.7.1. Mild
        • 7.2.7.2. Moderate
        • 7.2.7.3. Severe
      • 7.2.8. Global Period Cramp Pain Killer Region
        • 7.2.8.1. South America
          • 7.2.8.1.1. Brazil
          • 7.2.8.1.2. Argentina
          • 7.2.8.1.3. Rest of South America
        • 7.2.8.2. Asia Pacific
          • 7.2.8.2.1. China
          • 7.2.8.2.2. Japan
          • 7.2.8.2.3. India
          • 7.2.8.2.4. South Korea
          • 7.2.8.2.5. Taiwan
          • 7.2.8.2.6. Australia
          • 7.2.8.2.7. Rest of Asia-Pacific
        • 7.2.8.3. Europe
          • 7.2.8.3.1. Germany
          • 7.2.8.3.2. France
          • 7.2.8.3.3. Italy
          • 7.2.8.3.4. United Kingdom
          • 7.2.8.3.5. Netherlands
          • 7.2.8.3.6. Rest of Europe
        • 7.2.8.4. MEA
          • 7.2.8.4.1. Middle East
          • 7.2.8.4.2. Africa
        • 7.2.8.5. North America
          • 7.2.8.5.1. United States
          • 7.2.8.5.2. Canada
          • 7.2.8.5.3. Mexico
    • 7.3. Global Period Cramp Pain Killer (Volume)
      • 7.3.1. Global Period Cramp Pain Killer by: Type (Volume)
        • 7.3.1.1. Ibuprofen
        • 7.3.1.2. Ketoprofen
        • 7.3.1.3. Naproxen
      • 7.3.2. Global Period Cramp Pain Killer by: Application (Volume)
        • 7.3.2.1. Endometriosis
        • 7.3.2.2. Uterine Fibroids
        • 7.3.2.3. Adenomyosis
        • 7.3.2.4. Pelvic Inflammatory Disease
        • 7.3.2.5. Cervical Stenosis
      • 7.3.3. Global Period Cramp Pain Killer by: Mode of Prescription (Volume)
        • 7.3.3.1. Over the Counter
        • 7.3.3.2. Prescription
      • 7.3.4. Global Period Cramp Pain Killer by: End Users (Volume)
        • 7.3.4.1. Individual Use
        • 7.3.4.2. Specialty Centers
      • 7.3.5. Global Period Cramp Pain Killer by: Route of Administration (Volume)
        • 7.3.5.1. Oral
        • 7.3.5.2. Parenteral
        • 7.3.5.3. Implants
      • 7.3.6. Global Period Cramp Pain Killer by: Distribution Channel (Volume)
        • 7.3.6.1. Pharmacies
        • 7.3.6.2. Retail Sales
        • 7.3.6.3. Others
      • 7.3.7. Global Period Cramp Pain Killer by: Pain Type (Volume)
        • 7.3.7.1. Mild
        • 7.3.7.2. Moderate
        • 7.3.7.3. Severe
      • 7.3.8. Global Period Cramp Pain Killer Region
        • 7.3.8.1. South America
          • 7.3.8.1.1. Brazil
          • 7.3.8.1.2. Argentina
          • 7.3.8.1.3. Rest of South America
        • 7.3.8.2. Asia Pacific
          • 7.3.8.2.1. China
          • 7.3.8.2.2. Japan
          • 7.3.8.2.3. India
          • 7.3.8.2.4. South Korea
          • 7.3.8.2.5. Taiwan
          • 7.3.8.2.6. Australia
          • 7.3.8.2.7. Rest of Asia-Pacific
        • 7.3.8.3. Europe
          • 7.3.8.3.1. Germany
          • 7.3.8.3.2. France
          • 7.3.8.3.3. Italy
          • 7.3.8.3.4. United Kingdom
          • 7.3.8.3.5. Netherlands
          • 7.3.8.3.6. Rest of Europe
        • 7.3.8.4. MEA
          • 7.3.8.4.1. Middle East
          • 7.3.8.4.2. Africa
        • 7.3.8.5. North America
          • 7.3.8.5.1. United States
          • 7.3.8.5.2. Canada
          • 7.3.8.5.3. Mexico
    • 7.4. Global Period Cramp Pain Killer (Price)
      • 7.4.1. Global Period Cramp Pain Killer by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Period Cramp Pain Killer: by Type(USD Million)
  • Table 2. Period Cramp Pain Killer Ibuprofen , by Region USD Million (2015-2020)
  • Table 3. Period Cramp Pain Killer Ketoprofen , by Region USD Million (2015-2020)
  • Table 4. Period Cramp Pain Killer Naproxen , by Region USD Million (2015-2020)
  • Table 5. Period Cramp Pain Killer: by Application(USD Million)
  • Table 6. Period Cramp Pain Killer Endometriosis , by Region USD Million (2015-2020)
  • Table 7. Period Cramp Pain Killer Uterine Fibroids , by Region USD Million (2015-2020)
  • Table 8. Period Cramp Pain Killer Adenomyosis , by Region USD Million (2015-2020)
  • Table 9. Period Cramp Pain Killer Pelvic Inflammatory Disease , by Region USD Million (2015-2020)
  • Table 10. Period Cramp Pain Killer Cervical Stenosis , by Region USD Million (2015-2020)
  • Table 11. Period Cramp Pain Killer: by Mode of Prescription(USD Million)
  • Table 12. Period Cramp Pain Killer Over the Counter , by Region USD Million (2015-2020)
  • Table 13. Period Cramp Pain Killer Prescription , by Region USD Million (2015-2020)
  • Table 14. Period Cramp Pain Killer: by End Users(USD Million)
  • Table 15. Period Cramp Pain Killer Individual Use , by Region USD Million (2015-2020)
  • Table 16. Period Cramp Pain Killer Specialty Centers , by Region USD Million (2015-2020)
  • Table 17. Period Cramp Pain Killer: by Route of Administration(USD Million)
  • Table 18. Period Cramp Pain Killer Oral , by Region USD Million (2015-2020)
  • Table 19. Period Cramp Pain Killer Parenteral , by Region USD Million (2015-2020)
  • Table 20. Period Cramp Pain Killer Implants , by Region USD Million (2015-2020)
  • Table 21. Period Cramp Pain Killer: by Distribution Channel(USD Million)
  • Table 22. Period Cramp Pain Killer Pharmacies , by Region USD Million (2015-2020)
  • Table 23. Period Cramp Pain Killer Retail Sales , by Region USD Million (2015-2020)
  • Table 24. Period Cramp Pain Killer Others , by Region USD Million (2015-2020)
  • Table 25. Period Cramp Pain Killer: by Pain Type(USD Million)
  • Table 26. Period Cramp Pain Killer Mild , by Region USD Million (2015-2020)
  • Table 27. Period Cramp Pain Killer Moderate , by Region USD Million (2015-2020)
  • Table 28. Period Cramp Pain Killer Severe , by Region USD Million (2015-2020)
  • Table 29. South America Period Cramp Pain Killer, by Country USD Million (2015-2020)
  • Table 30. South America Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 31. South America Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 32. South America Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 33. South America Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 34. South America Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 35. South America Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 36. South America Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 37. Brazil Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 38. Brazil Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 39. Brazil Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 40. Brazil Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 41. Brazil Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 42. Brazil Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 43. Brazil Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 44. Argentina Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 45. Argentina Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 46. Argentina Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 47. Argentina Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 48. Argentina Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 49. Argentina Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 50. Argentina Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 51. Rest of South America Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 52. Rest of South America Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 53. Rest of South America Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 54. Rest of South America Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 55. Rest of South America Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 56. Rest of South America Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 57. Rest of South America Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 58. Asia Pacific Period Cramp Pain Killer, by Country USD Million (2015-2020)
  • Table 59. Asia Pacific Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 60. Asia Pacific Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 61. Asia Pacific Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 62. Asia Pacific Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 63. Asia Pacific Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 64. Asia Pacific Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 65. Asia Pacific Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 66. China Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 67. China Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 68. China Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 69. China Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 70. China Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 71. China Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 72. China Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 73. Japan Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 74. Japan Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 75. Japan Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 76. Japan Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 77. Japan Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 78. Japan Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 79. Japan Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 80. India Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 81. India Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 82. India Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 83. India Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 84. India Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 85. India Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 86. India Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 87. South Korea Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 88. South Korea Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 89. South Korea Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 90. South Korea Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 91. South Korea Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 92. South Korea Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 93. South Korea Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 94. Taiwan Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 95. Taiwan Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 96. Taiwan Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 97. Taiwan Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 98. Taiwan Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 99. Taiwan Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 100. Taiwan Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 101. Australia Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 102. Australia Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 103. Australia Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 104. Australia Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 105. Australia Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 106. Australia Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 107. Australia Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 108. Rest of Asia-Pacific Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 109. Rest of Asia-Pacific Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 110. Rest of Asia-Pacific Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 111. Rest of Asia-Pacific Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 112. Rest of Asia-Pacific Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 113. Rest of Asia-Pacific Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 114. Rest of Asia-Pacific Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 115. Europe Period Cramp Pain Killer, by Country USD Million (2015-2020)
  • Table 116. Europe Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 117. Europe Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 118. Europe Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 119. Europe Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 120. Europe Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 121. Europe Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 122. Europe Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 123. Germany Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 124. Germany Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 125. Germany Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 126. Germany Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 127. Germany Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 128. Germany Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 129. Germany Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 130. France Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 131. France Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 132. France Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 133. France Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 134. France Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 135. France Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 136. France Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 137. Italy Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 138. Italy Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 139. Italy Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 140. Italy Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 141. Italy Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 142. Italy Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 143. Italy Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 144. United Kingdom Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 145. United Kingdom Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 146. United Kingdom Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 147. United Kingdom Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 148. United Kingdom Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 149. United Kingdom Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 150. United Kingdom Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 151. Netherlands Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 152. Netherlands Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 153. Netherlands Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 154. Netherlands Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 155. Netherlands Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 156. Netherlands Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 157. Netherlands Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 158. Rest of Europe Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 159. Rest of Europe Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 160. Rest of Europe Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 161. Rest of Europe Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 162. Rest of Europe Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 163. Rest of Europe Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 164. Rest of Europe Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 165. MEA Period Cramp Pain Killer, by Country USD Million (2015-2020)
  • Table 166. MEA Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 167. MEA Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 168. MEA Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 169. MEA Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 170. MEA Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 171. MEA Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 172. MEA Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 173. Middle East Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 174. Middle East Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 175. Middle East Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 176. Middle East Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 177. Middle East Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 178. Middle East Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 179. Middle East Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 180. Africa Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 181. Africa Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 182. Africa Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 183. Africa Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 184. Africa Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 185. Africa Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 186. Africa Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 187. North America Period Cramp Pain Killer, by Country USD Million (2015-2020)
  • Table 188. North America Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 189. North America Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 190. North America Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 191. North America Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 192. North America Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 193. North America Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 194. North America Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 195. United States Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 196. United States Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 197. United States Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 198. United States Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 199. United States Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 200. United States Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 201. United States Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 202. Canada Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 203. Canada Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 204. Canada Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 205. Canada Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 206. Canada Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 207. Canada Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 208. Canada Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 209. Mexico Period Cramp Pain Killer, by Type USD Million (2015-2020)
  • Table 210. Mexico Period Cramp Pain Killer, by Application USD Million (2015-2020)
  • Table 211. Mexico Period Cramp Pain Killer, by Mode of Prescription USD Million (2015-2020)
  • Table 212. Mexico Period Cramp Pain Killer, by End Users USD Million (2015-2020)
  • Table 213. Mexico Period Cramp Pain Killer, by Route of Administration USD Million (2015-2020)
  • Table 214. Mexico Period Cramp Pain Killer, by Distribution Channel USD Million (2015-2020)
  • Table 215. Mexico Period Cramp Pain Killer, by Pain Type USD Million (2015-2020)
  • Table 216. Period Cramp Pain Killer Sales: by Type(K Tons)
  • Table 217. Period Cramp Pain Killer Sales Ibuprofen , by Region K Tons (2015-2020)
  • Table 218. Period Cramp Pain Killer Sales Ketoprofen , by Region K Tons (2015-2020)
  • Table 219. Period Cramp Pain Killer Sales Naproxen , by Region K Tons (2015-2020)
  • Table 220. Period Cramp Pain Killer Sales: by Application(K Tons)
  • Table 221. Period Cramp Pain Killer Sales Endometriosis , by Region K Tons (2015-2020)
  • Table 222. Period Cramp Pain Killer Sales Uterine Fibroids , by Region K Tons (2015-2020)
  • Table 223. Period Cramp Pain Killer Sales Adenomyosis , by Region K Tons (2015-2020)
  • Table 224. Period Cramp Pain Killer Sales Pelvic Inflammatory Disease , by Region K Tons (2015-2020)
  • Table 225. Period Cramp Pain Killer Sales Cervical Stenosis , by Region K Tons (2015-2020)
  • Table 226. Period Cramp Pain Killer Sales: by Mode of Prescription(K Tons)
  • Table 227. Period Cramp Pain Killer Sales Over the Counter , by Region K Tons (2015-2020)
  • Table 228. Period Cramp Pain Killer Sales Prescription , by Region K Tons (2015-2020)
  • Table 229. Period Cramp Pain Killer Sales: by End Users(K Tons)
  • Table 230. Period Cramp Pain Killer Sales Individual Use , by Region K Tons (2015-2020)
  • Table 231. Period Cramp Pain Killer Sales Specialty Centers , by Region K Tons (2015-2020)
  • Table 232. Period Cramp Pain Killer Sales: by Route of Administration(K Tons)
  • Table 233. Period Cramp Pain Killer Sales Oral , by Region K Tons (2015-2020)
  • Table 234. Period Cramp Pain Killer Sales Parenteral , by Region K Tons (2015-2020)
  • Table 235. Period Cramp Pain Killer Sales Implants , by Region K Tons (2015-2020)
  • Table 236. Period Cramp Pain Killer Sales: by Distribution Channel(K Tons)
  • Table 237. Period Cramp Pain Killer Sales Pharmacies , by Region K Tons (2015-2020)
  • Table 238. Period Cramp Pain Killer Sales Retail Sales , by Region K Tons (2015-2020)
  • Table 239. Period Cramp Pain Killer Sales Others , by Region K Tons (2015-2020)
  • Table 240. Period Cramp Pain Killer Sales: by Pain Type(K Tons)
  • Table 241. Period Cramp Pain Killer Sales Mild , by Region K Tons (2015-2020)
  • Table 242. Period Cramp Pain Killer Sales Moderate , by Region K Tons (2015-2020)
  • Table 243. Period Cramp Pain Killer Sales Severe , by Region K Tons (2015-2020)
  • Table 244. South America Period Cramp Pain Killer Sales, by Country K Tons (2015-2020)
  • Table 245. South America Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 246. South America Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 247. South America Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 248. South America Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 249. South America Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 250. South America Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 251. South America Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 252. Brazil Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 253. Brazil Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 254. Brazil Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 255. Brazil Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 256. Brazil Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 257. Brazil Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 258. Brazil Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 259. Argentina Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 260. Argentina Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 261. Argentina Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 262. Argentina Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 263. Argentina Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 264. Argentina Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 265. Argentina Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 266. Rest of South America Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 267. Rest of South America Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 268. Rest of South America Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 269. Rest of South America Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 270. Rest of South America Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 271. Rest of South America Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 272. Rest of South America Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 273. Asia Pacific Period Cramp Pain Killer Sales, by Country K Tons (2015-2020)
  • Table 274. Asia Pacific Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 275. Asia Pacific Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 276. Asia Pacific Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 277. Asia Pacific Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 278. Asia Pacific Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 279. Asia Pacific Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 280. Asia Pacific Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 281. China Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 282. China Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 283. China Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 284. China Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 285. China Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 286. China Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 287. China Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 288. Japan Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 289. Japan Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 290. Japan Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 291. Japan Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 292. Japan Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 293. Japan Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 294. Japan Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 295. India Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 296. India Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 297. India Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 298. India Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 299. India Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 300. India Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 301. India Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 302. South Korea Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 303. South Korea Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 304. South Korea Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 305. South Korea Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 306. South Korea Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 307. South Korea Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 308. South Korea Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 309. Taiwan Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 310. Taiwan Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 311. Taiwan Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 312. Taiwan Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 313. Taiwan Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 314. Taiwan Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 315. Taiwan Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 316. Australia Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 317. Australia Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 318. Australia Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 319. Australia Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 320. Australia Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 321. Australia Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 322. Australia Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 323. Rest of Asia-Pacific Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 324. Rest of Asia-Pacific Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 325. Rest of Asia-Pacific Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 326. Rest of Asia-Pacific Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 327. Rest of Asia-Pacific Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 328. Rest of Asia-Pacific Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 329. Rest of Asia-Pacific Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 330. Europe Period Cramp Pain Killer Sales, by Country K Tons (2015-2020)
  • Table 331. Europe Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 332. Europe Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 333. Europe Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 334. Europe Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 335. Europe Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 336. Europe Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 337. Europe Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 338. Germany Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 339. Germany Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 340. Germany Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 341. Germany Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 342. Germany Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 343. Germany Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 344. Germany Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 345. France Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 346. France Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 347. France Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 348. France Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 349. France Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 350. France Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 351. France Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 352. Italy Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 353. Italy Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 354. Italy Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 355. Italy Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 356. Italy Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 357. Italy Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 358. Italy Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 359. United Kingdom Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 360. United Kingdom Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 361. United Kingdom Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 362. United Kingdom Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 363. United Kingdom Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 364. United Kingdom Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 365. United Kingdom Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 366. Netherlands Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 367. Netherlands Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 368. Netherlands Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 369. Netherlands Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 370. Netherlands Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 371. Netherlands Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 372. Netherlands Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 373. Rest of Europe Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 374. Rest of Europe Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 375. Rest of Europe Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 376. Rest of Europe Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 377. Rest of Europe Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 378. Rest of Europe Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 379. Rest of Europe Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 380. MEA Period Cramp Pain Killer Sales, by Country K Tons (2015-2020)
  • Table 381. MEA Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 382. MEA Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 383. MEA Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 384. MEA Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 385. MEA Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 386. MEA Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 387. MEA Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 388. Middle East Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 389. Middle East Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 390. Middle East Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 391. Middle East Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 392. Middle East Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 393. Middle East Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 394. Middle East Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 395. Africa Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 396. Africa Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 397. Africa Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 398. Africa Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 399. Africa Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 400. Africa Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 401. Africa Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 402. North America Period Cramp Pain Killer Sales, by Country K Tons (2015-2020)
  • Table 403. North America Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 404. North America Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 405. North America Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 406. North America Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 407. North America Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 408. North America Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 409. North America Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 410. United States Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 411. United States Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 412. United States Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 413. United States Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 414. United States Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 415. United States Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 416. United States Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 417. Canada Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 418. Canada Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 419. Canada Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 420. Canada Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 421. Canada Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 422. Canada Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 423. Canada Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 424. Mexico Period Cramp Pain Killer Sales, by Type K Tons (2015-2020)
  • Table 425. Mexico Period Cramp Pain Killer Sales, by Application K Tons (2015-2020)
  • Table 426. Mexico Period Cramp Pain Killer Sales, by Mode of Prescription K Tons (2015-2020)
  • Table 427. Mexico Period Cramp Pain Killer Sales, by End Users K Tons (2015-2020)
  • Table 428. Mexico Period Cramp Pain Killer Sales, by Route of Administration K Tons (2015-2020)
  • Table 429. Mexico Period Cramp Pain Killer Sales, by Distribution Channel K Tons (2015-2020)
  • Table 430. Mexico Period Cramp Pain Killer Sales, by Pain Type K Tons (2015-2020)
  • Table 431. Period Cramp Pain Killer: by Type(USD/Units)
  • Table 432. Company Basic Information, Sales Area and Its Competitors
  • Table 433. Company Basic Information, Sales Area and Its Competitors
  • Table 434. Company Basic Information, Sales Area and Its Competitors
  • Table 435. Company Basic Information, Sales Area and Its Competitors
  • Table 436. Company Basic Information, Sales Area and Its Competitors
  • Table 437. Company Basic Information, Sales Area and Its Competitors
  • Table 438. Company Basic Information, Sales Area and Its Competitors
  • Table 439. Company Basic Information, Sales Area and Its Competitors
  • Table 440. Company Basic Information, Sales Area and Its Competitors
  • Table 441. Company Basic Information, Sales Area and Its Competitors
  • Table 442. Company Basic Information, Sales Area and Its Competitors
  • Table 443. Company Basic Information, Sales Area and Its Competitors
  • Table 444. Company Basic Information, Sales Area and Its Competitors
  • Table 445. Company Basic Information, Sales Area and Its Competitors
  • Table 446. Company Basic Information, Sales Area and Its Competitors
  • Table 447. Company Basic Information, Sales Area and Its Competitors
  • Table 448. Period Cramp Pain Killer: by Type(USD Million)
  • Table 449. Period Cramp Pain Killer Ibuprofen , by Region USD Million (2021-2026)
  • Table 450. Period Cramp Pain Killer Ketoprofen , by Region USD Million (2021-2026)
  • Table 451. Period Cramp Pain Killer Naproxen , by Region USD Million (2021-2026)
  • Table 452. Period Cramp Pain Killer: by Application(USD Million)
  • Table 453. Period Cramp Pain Killer Endometriosis , by Region USD Million (2021-2026)
  • Table 454. Period Cramp Pain Killer Uterine Fibroids , by Region USD Million (2021-2026)
  • Table 455. Period Cramp Pain Killer Adenomyosis , by Region USD Million (2021-2026)
  • Table 456. Period Cramp Pain Killer Pelvic Inflammatory Disease , by Region USD Million (2021-2026)
  • Table 457. Period Cramp Pain Killer Cervical Stenosis , by Region USD Million (2021-2026)
  • Table 458. Period Cramp Pain Killer: by Mode of Prescription(USD Million)
  • Table 459. Period Cramp Pain Killer Over the Counter , by Region USD Million (2021-2026)
  • Table 460. Period Cramp Pain Killer Prescription , by Region USD Million (2021-2026)
  • Table 461. Period Cramp Pain Killer: by End Users(USD Million)
  • Table 462. Period Cramp Pain Killer Individual Use , by Region USD Million (2021-2026)
  • Table 463. Period Cramp Pain Killer Specialty Centers , by Region USD Million (2021-2026)
  • Table 464. Period Cramp Pain Killer: by Route of Administration(USD Million)
  • Table 465. Period Cramp Pain Killer Oral , by Region USD Million (2021-2026)
  • Table 466. Period Cramp Pain Killer Parenteral , by Region USD Million (2021-2026)
  • Table 467. Period Cramp Pain Killer Implants , by Region USD Million (2021-2026)
  • Table 468. Period Cramp Pain Killer: by Distribution Channel(USD Million)
  • Table 469. Period Cramp Pain Killer Pharmacies , by Region USD Million (2021-2026)
  • Table 470. Period Cramp Pain Killer Retail Sales , by Region USD Million (2021-2026)
  • Table 471. Period Cramp Pain Killer Others , by Region USD Million (2021-2026)
  • Table 472. Period Cramp Pain Killer: by Pain Type(USD Million)
  • Table 473. Period Cramp Pain Killer Mild , by Region USD Million (2021-2026)
  • Table 474. Period Cramp Pain Killer Moderate , by Region USD Million (2021-2026)
  • Table 475. Period Cramp Pain Killer Severe , by Region USD Million (2021-2026)
  • Table 476. South America Period Cramp Pain Killer, by Country USD Million (2021-2026)
  • Table 477. South America Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 478. South America Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 479. South America Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 480. South America Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 481. South America Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 482. South America Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 483. South America Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 484. Brazil Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 485. Brazil Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 486. Brazil Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 487. Brazil Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 488. Brazil Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 489. Brazil Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 490. Brazil Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 491. Argentina Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 492. Argentina Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 493. Argentina Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 494. Argentina Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 495. Argentina Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 496. Argentina Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 497. Argentina Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 498. Rest of South America Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 499. Rest of South America Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 500. Rest of South America Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 501. Rest of South America Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 502. Rest of South America Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 503. Rest of South America Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 504. Rest of South America Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 505. Asia Pacific Period Cramp Pain Killer, by Country USD Million (2021-2026)
  • Table 506. Asia Pacific Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 507. Asia Pacific Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 508. Asia Pacific Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 509. Asia Pacific Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 510. Asia Pacific Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 511. Asia Pacific Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 512. Asia Pacific Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 513. China Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 514. China Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 515. China Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 516. China Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 517. China Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 518. China Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 519. China Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 520. Japan Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 521. Japan Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 522. Japan Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 523. Japan Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 524. Japan Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 525. Japan Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 526. Japan Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 527. India Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 528. India Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 529. India Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 530. India Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 531. India Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 532. India Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 533. India Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 534. South Korea Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 535. South Korea Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 536. South Korea Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 537. South Korea Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 538. South Korea Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 539. South Korea Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 540. South Korea Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 541. Taiwan Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 542. Taiwan Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 543. Taiwan Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 544. Taiwan Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 545. Taiwan Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 546. Taiwan Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 547. Taiwan Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 548. Australia Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 549. Australia Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 550. Australia Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 551. Australia Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 552. Australia Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 553. Australia Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 554. Australia Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 555. Rest of Asia-Pacific Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 556. Rest of Asia-Pacific Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 557. Rest of Asia-Pacific Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 558. Rest of Asia-Pacific Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 559. Rest of Asia-Pacific Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 560. Rest of Asia-Pacific Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 561. Rest of Asia-Pacific Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 562. Europe Period Cramp Pain Killer, by Country USD Million (2021-2026)
  • Table 563. Europe Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 564. Europe Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 565. Europe Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 566. Europe Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 567. Europe Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 568. Europe Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 569. Europe Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 570. Germany Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 571. Germany Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 572. Germany Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 573. Germany Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 574. Germany Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 575. Germany Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 576. Germany Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 577. France Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 578. France Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 579. France Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 580. France Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 581. France Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 582. France Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 583. France Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 584. Italy Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 585. Italy Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 586. Italy Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 587. Italy Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 588. Italy Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 589. Italy Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 590. Italy Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 591. United Kingdom Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 592. United Kingdom Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 593. United Kingdom Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 594. United Kingdom Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 595. United Kingdom Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 596. United Kingdom Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 597. United Kingdom Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 598. Netherlands Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 599. Netherlands Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 600. Netherlands Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 601. Netherlands Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 602. Netherlands Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 603. Netherlands Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 604. Netherlands Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 605. Rest of Europe Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 606. Rest of Europe Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 607. Rest of Europe Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 608. Rest of Europe Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 609. Rest of Europe Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 610. Rest of Europe Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 611. Rest of Europe Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 612. MEA Period Cramp Pain Killer, by Country USD Million (2021-2026)
  • Table 613. MEA Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 614. MEA Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 615. MEA Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 616. MEA Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 617. MEA Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 618. MEA Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 619. MEA Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 620. Middle East Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 621. Middle East Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 622. Middle East Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 623. Middle East Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 624. Middle East Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 625. Middle East Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 626. Middle East Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 627. Africa Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 628. Africa Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 629. Africa Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 630. Africa Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 631. Africa Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 632. Africa Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 633. Africa Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 634. North America Period Cramp Pain Killer, by Country USD Million (2021-2026)
  • Table 635. North America Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 636. North America Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 637. North America Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 638. North America Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 639. North America Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 640. North America Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 641. North America Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 642. United States Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 643. United States Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 644. United States Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 645. United States Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 646. United States Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 647. United States Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 648. United States Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 649. Canada Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 650. Canada Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 651. Canada Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 652. Canada Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 653. Canada Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 654. Canada Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 655. Canada Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 656. Mexico Period Cramp Pain Killer, by Type USD Million (2021-2026)
  • Table 657. Mexico Period Cramp Pain Killer, by Application USD Million (2021-2026)
  • Table 658. Mexico Period Cramp Pain Killer, by Mode of Prescription USD Million (2021-2026)
  • Table 659. Mexico Period Cramp Pain Killer, by End Users USD Million (2021-2026)
  • Table 660. Mexico Period Cramp Pain Killer, by Route of Administration USD Million (2021-2026)
  • Table 661. Mexico Period Cramp Pain Killer, by Distribution Channel USD Million (2021-2026)
  • Table 662. Mexico Period Cramp Pain Killer, by Pain Type USD Million (2021-2026)
  • Table 663. Period Cramp Pain Killer Sales: by Type(K Tons)
  • Table 664. Period Cramp Pain Killer Sales Ibuprofen , by Region K Tons (2021-2026)
  • Table 665. Period Cramp Pain Killer Sales Ketoprofen , by Region K Tons (2021-2026)
  • Table 666. Period Cramp Pain Killer Sales Naproxen , by Region K Tons (2021-2026)
  • Table 667. Period Cramp Pain Killer Sales: by Application(K Tons)
  • Table 668. Period Cramp Pain Killer Sales Endometriosis , by Region K Tons (2021-2026)
  • Table 669. Period Cramp Pain Killer Sales Uterine Fibroids , by Region K Tons (2021-2026)
  • Table 670. Period Cramp Pain Killer Sales Adenomyosis , by Region K Tons (2021-2026)
  • Table 671. Period Cramp Pain Killer Sales Pelvic Inflammatory Disease , by Region K Tons (2021-2026)
  • Table 672. Period Cramp Pain Killer Sales Cervical Stenosis , by Region K Tons (2021-2026)
  • Table 673. Period Cramp Pain Killer Sales: by Mode of Prescription(K Tons)
  • Table 674. Period Cramp Pain Killer Sales Over the Counter , by Region K Tons (2021-2026)
  • Table 675. Period Cramp Pain Killer Sales Prescription , by Region K Tons (2021-2026)
  • Table 676. Period Cramp Pain Killer Sales: by End Users(K Tons)
  • Table 677. Period Cramp Pain Killer Sales Individual Use , by Region K Tons (2021-2026)
  • Table 678. Period Cramp Pain Killer Sales Specialty Centers , by Region K Tons (2021-2026)
  • Table 679. Period Cramp Pain Killer Sales: by Route of Administration(K Tons)
  • Table 680. Period Cramp Pain Killer Sales Oral , by Region K Tons (2021-2026)
  • Table 681. Period Cramp Pain Killer Sales Parenteral , by Region K Tons (2021-2026)
  • Table 682. Period Cramp Pain Killer Sales Implants , by Region K Tons (2021-2026)
  • Table 683. Period Cramp Pain Killer Sales: by Distribution Channel(K Tons)
  • Table 684. Period Cramp Pain Killer Sales Pharmacies , by Region K Tons (2021-2026)
  • Table 685. Period Cramp Pain Killer Sales Retail Sales , by Region K Tons (2021-2026)
  • Table 686. Period Cramp Pain Killer Sales Others , by Region K Tons (2021-2026)
  • Table 687. Period Cramp Pain Killer Sales: by Pain Type(K Tons)
  • Table 688. Period Cramp Pain Killer Sales Mild , by Region K Tons (2021-2026)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Period Cramp Pain Killer: by Type USD Million (2015-2020)
  • Figure 5. Global Period Cramp Pain Killer: by Application USD Million (2015-2020)
  • Figure 6. Global Period Cramp Pain Killer: by Mode of Prescription USD Million (2015-2020)
  • Figure 7. Global Period Cramp Pain Killer: by End Users USD Million (2015-2020)
  • Figure 8. Global Period Cramp Pain Killer: by Route of Administration USD Million (2015-2020)
  • Figure 9. Global Period Cramp Pain Killer: by Distribution Channel USD Million (2015-2020)
  • Figure 10. Global Period Cramp Pain Killer: by Pain Type USD Million (2015-2020)
  • Figure 11. South America Period Cramp Pain Killer Share (%), by Country
  • Figure 12. Asia Pacific Period Cramp Pain Killer Share (%), by Country
  • Figure 13. Europe Period Cramp Pain Killer Share (%), by Country
  • Figure 14. MEA Period Cramp Pain Killer Share (%), by Country
  • Figure 15. North America Period Cramp Pain Killer Share (%), by Country
  • Figure 16. Global Period Cramp Pain Killer: by Type K Tons (2015-2020)
  • Figure 17. Global Period Cramp Pain Killer: by Application K Tons (2015-2020)
  • Figure 18. Global Period Cramp Pain Killer: by Mode of Prescription K Tons (2015-2020)
  • Figure 19. Global Period Cramp Pain Killer: by End Users K Tons (2015-2020)
  • Figure 20. Global Period Cramp Pain Killer: by Route of Administration K Tons (2015-2020)
  • Figure 21. Global Period Cramp Pain Killer: by Distribution Channel K Tons (2015-2020)
  • Figure 22. Global Period Cramp Pain Killer: by Pain Type K Tons (2015-2020)
  • Figure 23. South America Period Cramp Pain Killer Share (%), by Country
  • Figure 24. Asia Pacific Period Cramp Pain Killer Share (%), by Country
  • Figure 25. Europe Period Cramp Pain Killer Share (%), by Country
  • Figure 26. MEA Period Cramp Pain Killer Share (%), by Country
  • Figure 27. North America Period Cramp Pain Killer Share (%), by Country
  • Figure 28. Global Period Cramp Pain Killer: by Type USD/Units (2015-2020)
  • Figure 29. Global Period Cramp Pain Killer share by Players 2020 (%)
  • Figure 30. Global Period Cramp Pain Killer share by Players (Top 3) 2020(%)
  • Figure 31. Global Period Cramp Pain Killer share by Players (Top 5) 2020(%)
  • Figure 32. BCG Matrix for key Companies
  • Figure 33. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 35. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 37. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 39. Teva Pharmaceuticals USA, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Teva Pharmaceuticals USA, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Color Seven Co., Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 42. Color Seven Co., Ltd. (South Korea) Revenue: by Geography 2020
  • Figure 43. Beurer GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Beurer GmbH (Germany) Revenue: by Geography 2020
  • Figure 45. Mylan N. V. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Mylan N. V. (United States) Revenue: by Geography 2020
  • Figure 47. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 48. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2020
  • Figure 49. PMS4PMS, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 50. PMS4PMS, LLC (United States) Revenue: by Geography 2020
  • Figure 51. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 52. Sanofi (France) Revenue: by Geography 2020
  • Figure 53. Nobelpharma Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 54. Nobelpharma Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 55. ObsEva (Switzerland) Revenue, Net Income and Gross profit
  • Figure 56. ObsEva (Switzerland) Revenue: by Geography 2020
  • Figure 57. Myovant Sciences Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 58. Myovant Sciences Ltd. (United Kingdom) Revenue: by Geography 2020
  • Figure 59. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 60. AbbVie Inc. (United States) Revenue: by Geography 2020
  • Figure 61. LIVIA (United States) Revenue, Net Income and Gross profit
  • Figure 62. LIVIA (United States) Revenue: by Geography 2020
  • Figure 63. Alvogen (United States) Revenue, Net Income and Gross profit
  • Figure 64. Alvogen (United States) Revenue: by Geography 2020
  • Figure 65. Global Period Cramp Pain Killer: by Type USD Million (2021-2026)
  • Figure 66. Global Period Cramp Pain Killer: by Application USD Million (2021-2026)
  • Figure 67. Global Period Cramp Pain Killer: by Mode of Prescription USD Million (2021-2026)
  • Figure 68. Global Period Cramp Pain Killer: by End Users USD Million (2021-2026)
  • Figure 69. Global Period Cramp Pain Killer: by Route of Administration USD Million (2021-2026)
  • Figure 70. Global Period Cramp Pain Killer: by Distribution Channel USD Million (2021-2026)
  • Figure 71. Global Period Cramp Pain Killer: by Pain Type USD Million (2021-2026)
  • Figure 72. South America Period Cramp Pain Killer Share (%), by Country
  • Figure 73. Asia Pacific Period Cramp Pain Killer Share (%), by Country
  • Figure 74. Europe Period Cramp Pain Killer Share (%), by Country
  • Figure 75. MEA Period Cramp Pain Killer Share (%), by Country
  • Figure 76. North America Period Cramp Pain Killer Share (%), by Country
  • Figure 77. Global Period Cramp Pain Killer: by Type K Tons (2021-2026)
  • Figure 78. Global Period Cramp Pain Killer: by Application K Tons (2021-2026)
  • Figure 79. Global Period Cramp Pain Killer: by Mode of Prescription K Tons (2021-2026)
  • Figure 80. Global Period Cramp Pain Killer: by End Users K Tons (2021-2026)
  • Figure 81. Global Period Cramp Pain Killer: by Route of Administration K Tons (2021-2026)
  • Figure 82. Global Period Cramp Pain Killer: by Distribution Channel K Tons (2021-2026)
  • Figure 83. Global Period Cramp Pain Killer: by Pain Type K Tons (2021-2026)
  • Figure 84. South America Period Cramp Pain Killer Share (%), by Country
  • Figure 85. Asia Pacific Period Cramp Pain Killer Share (%), by Country
  • Figure 86. Europe Period Cramp Pain Killer Share (%), by Country
  • Figure 87. MEA Period Cramp Pain Killer Share (%), by Country
  • Figure 88. North America Period Cramp Pain Killer Share (%), by Country
  • Figure 89. Global Period Cramp Pain Killer: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Bayer AG (Germany)
  • GlaxoSmithKline plc (United Kingdom)
  • Pfizer Inc. (United States)
  • Teva Pharmaceuticals USA, Inc. (United States)
  • Color Seven Co., Ltd. (South Korea)
  • Beurer GmbH (Germany)
  • Mylan N. V. (United States)
  • Boehringer Ingelheim International GmbH (Germany)
  • PMS4PMS, LLC (United States)
  • Sanofi (France)
  • Nobelpharma Co., Ltd. (Japan)
  • ObsEva (Switzerland)
  • Myovant Sciences Ltd. (United Kingdom)
  • AbbVie Inc. (United States)
  • LIVIA (United States)
  • Alvogen (United States)
Additional players considered in the study are as follows:
Cumberland Pharmaceuticals Inc. (United States) , Lupin Pharmaceuticals, Inc. (India) , Janssen Pharmaceuticals, Inc. (United States) , Sun Pharmaceutical Industries Ltd. (India)
Select User Access Type

Key Highlights of Report


Apr 2021 227 Pages 86 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Period Cramp Pain Killer Market Quantitative research analysis
Global Period Cramp Pain Killer Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Period Cramp Pain Killer market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Period Cramp Pain Killer market are Bayer AG (Germany), GlaxoSmithKline plc (United Kingdom), Pfizer Inc. (United States), Teva Pharmaceuticals USA, Inc. (United States), Color Seven Co., Ltd. (South Korea), Beurer GmbH (Germany), Mylan N. V. (United States), Boehringer Ingelheim International GmbH (Germany), PMS4PMS, LLC (United States), Sanofi (France), Nobelpharma Co., Ltd. (Japan), ObsEva (Switzerland), Myovant Sciences Ltd. (United Kingdom), AbbVie Inc. (United States), LIVIA (United States) and Alvogen (United States), to name a few.
In this highly competitive & fast evolving Period Cramp Pain Killer industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Period Cramp Pain Killer Market Report?

Have a Query? Click Here

Other Related Reports

DTaP Vaccine  Comprehensive Study by Type (Diphtheria, Tetanus, Pertussis), Application (Adult, Pediatric), Product Type (Generic Drug, Branded Drug), End User (Hospitals, Clinics, Vaccination Center...
$ 3500
Eszopiclone Comprehensive Study by Type (Eszopiclone 1mg Tablet, Eszopiclone 2mg Tablet, Eszopiclone 3mg Tablet), End-users (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Re...
$ 3350
Macrolide Drugs Comprehensive Study by Type (Erythromycin, Clarithromycin, Azithromycin, Dirithromycin, Roxithromycin, Troleandomycin, Fidaxomicin, Telithromycin), Application (Mycoplasma Pneumoniae,...
$ 3750
OTC Pet Medication Comprehensive Study by Application (Fleas & Ticks, Pain Relief & Arthritis, Dewormers, Others), Form (Chewables & Tablets, Capsules & Ointment, Sprays, Others), Distribution Channe...
$ 3650
Carglumic Acid Comprehensive Study by Form (Orally Disintegrating Tablets, Dispersible Tablets), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce Channel) Players and Region -...
$ 3500
Risedronate Sodiums Comprehensive Study by Type (Generic, Branded), Application (Hospital Use, Clinic Use), Risedronate Strength (5 mg, 30 mg, 35 mg), Dosage Form (Capsule, Tablet, Injection) Player...
$ 3500